Stay updated on Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial

Sign up to get notified when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.5.3 to v3.5.4, signaling a minor update to the site’s underlying tooling or documentation rather than to trial content.
    Difference
    0.1%
    Check dated 2026-05-16T09:16:27.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    New and removed dates indicate updates to the study record history, reflecting revisions to the registry timeline. This does not change the substantive aspects of the trial such as design, endpoints, or eligibility.
    Difference
    0.3%
    Check dated 2026-05-09T11:21:34.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page’s footer “Revision” version was updated from v3.5.2 to v3.5.3, indicating a site software/content management update rather than a change to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T22:41:27.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:18:29.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:50:59.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:41:23.000Z thumbnail image

Stay in the know with updates to Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.